Qvar RediHaler Side Effects
Generic name: beclomethasone
Medically reviewed by Drugs.com. Last updated on Mar 14, 2025.
Note: This document provides detailed information about Qvar RediHaler Side Effects associated with beclomethasone. Some dosage forms listed on this page may not apply specifically to the brand name Qvar RediHaler.
Applies to beclomethasone: inhalation aerosol liquid.
Serious side effects of Qvar RediHaler
Along with its needed effects, beclomethasone (the active ingredient contained in Qvar RediHaler) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking beclomethasone:
More common side effects
- body aches or pain
- congestion
- cough
- difficulty with breathing
- dryness or soreness of the throat
- fever
- hoarseness
- runny nose
- tender, swollen glands in the neck
- trouble swallowing
- voice changes
Incidence not known
- attack, assault, or force
- blindness
- blurred vision
- changes in behavior
- chills
- darkening of the skin
- decreased vision
- diarrhea
- dizziness
- eye pain
- fainting
- headache
- loss of appetite
- lower back or side pain
- mental depression
- nausea
- painful or difficult urination
- skin rash
- sore mouth or tongue
- tearing
- thoughts of killing oneself
- unusual tiredness or weakness
- vomiting
- white patches in the mouth or on the tongue
Other side effects of Qvar RediHaler
Some side effects of beclomethasone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common side effects
- cramps
- heavy bleeding
- pain
- pain or tenderness around the eyes and cheekbones
- stuffy or runny nose
- tightness of the chest
For healthcare professionals
Applies to beclomethasone: compounding powder, inhalation aerosol, inhalation aerosol with adapter.
General adverse events
The most commonly reported adverse reactions have included headache, pharyngitis, rhinitis, inhalation site and taste sensation.[Ref]
Endocrine
- Common (1% to 10%): Dysmenorrhea
- Uncommon (0.1% to 1%): Menorrhagia
- Very rare (less than 0.01%): Adrenal suppression, Cushing syndrome, cushingoid features[Ref]
Oral therapy:
Following 4 weeks of oral therapy for ulcerative colitis, a reduction of plasma cortisol levels has been observed in up to 25% of patients; HPA-axis function recovery is expected to be transient, however follow up data is lacking.[Ref]
Respiratory
- Very common (10% or more): Pharyngitis (up to 27%)
- Common (1% to 10%): Rhinitis, hoarseness, throat irritation, upper respiratory tract infection, dysphonia
- Uncommon (0.1% to 1%): Bronchitis, coughing, epistaxis
- Rare (0.01% to 0.1%): Acute asthma episode, hemoptysis, respiratory disorder, sinusitis
- Very rare (less than 0.01%): Paradoxical bronchospasm with wheezing
- Frequency not reported: Eosinophilic pneumonia[Ref]
Gastrointestinal
- Common (1% to 10%): Oral candidiasis of mouth and throat
- Uncommon (0.1% to 1%): Abdominal pain, constipation
- Rare (0.01% to 0.1%): Dyspepsia, unspecified gastrointestinal disorders, nausea, tongue discoloration, toothache[Ref]
Hypersensitivity
- Uncommon (0.1% to 1%): Hypersensitivity reactions including rashes, urticaria, pruritus, erythema
- Very rare (less than 0.01%): Hypersensitivity reactions including edema of the eyes, face, lips, and throat (angioedema), anaphylaxis and anaphylactoid reactions[Ref]
Ocular
- Frequency not reported: Glaucoma, cataracts
- Postmarketing reports: Blurred vision, central serous chorioretinopathy[Ref]
Psychiatric
- Uncommon (0.1% to 1%): Anxiety
- Rare (0.01% to 0.1%): Depression, insomnia, sleep disorders, hyperactivity, aggression, irritability (mostly in children)
- Postmarketing reports: Suicidal ideation[Ref]
Nervous system
- Very common (10% or more): Headache (up to 25%)
- Uncommon (0.1% to 1%): Dizziness, dysphonia, migraine
- Rare (0.01% to 0.1%): Neuropathy, tremor, vertigo[Ref]
Dermatologic
- Uncommon (0.1% to 1%): Rash, purpura
- Rare (0.01% to 0.1%): Photosensitivity reaction, skin disorder, urticaria
- Frequency not reported: Easy bruising, skin thinning[Ref]
Musculoskeletal
- Uncommon (0.1% to 1%): Myalgia, muscle cramps, back pain
- Very rare (less than 0.01%): Growth retardation, decrease in bone mineral density[Ref]
Cardiovascular
- Uncommon (0.1% to 1%): Chest pain, edema
- Rare (0.01% to 0.1%): Hypertension, palpitations, angina pectoris[Ref]
Local
- Common (1% to 10%): Inhalation site sensation and taste sensation[Ref]
Metabolic
- Uncommon (0.1% to 1%): Increased weight[Ref]
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. "Australian Product Information."
3. (2013) "Product Information. Qvar (beclomethasone)." Teva Pharmaceuticals USA
Frequently asked questions
More about Qvar RediHaler (beclomethasone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (188)
- Drug images
- Dosage information
- During pregnancy
- Drug class: inhaled corticosteroids
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Qvar RediHaler side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.